Thomas Woiwode
CIK 1619294 · last filed 2023-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$45.48M
Companies
8
Total Filings
49
Lifetime Open-Market Net
-$7.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 708,352 | $5.81 | $4.12M | $4.05M | 5 | 2023-05-26 |
| ALGS | Director | 1,462,389 | $5.28 | $7.72M | $3.00M | 5 | 2022-06-27 |
| TPST | Director | 1,171,094 | $1.26 | $1.48M | $5.00M | 5 | 2022-06-22 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 6,740 | $0.03 | $217 | $5.00M | 5 | 2021-08-27 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 18,822 | $4.36 | $82.1K | $0 | 14 | 2021-05-14 |
| CRSP | Director | 645,643 | $49.80 | $32.15M | -$27.67M | 7 | 2018-06-15 |
| CRISPR Therapeutics AG (PZRX) Delisted | Director | 4,959 | — | — | $2.15M | 6 | 2017-12-27 |
| BOLD | Director | 6,811 | $1.41 | $9.6K | $525.0K | 2 | 2016-08-25 |
Recent Filings · Page 5 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-02 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +3,449 | $0 | EDGAR |
| 2017-01-03 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +3,449 | $0 | EDGAR |
| 2016-12-23 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | +6,669,699 | $2.25M | EDGAR |
| 2016-12-01 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +3,509 | $0 | EDGAR |
| 2016-11-01 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +3,390 | $0 | EDGAR |
| 2016-10-20 | CRISPR Therapeutics AG (PZRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-25 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2016-07-25 | BOLD | Mixed | +1,806,832 | $525.0K | EDGAR |
| 2016-07-01 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +24,155 | $0 | EDGAR |
Showing 41–49 of 49
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.